📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout. (2019)

First Author: Hill-McManus D

Attributed to: Renewal of the Network of Hubs for Trials Methodology Research. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1454

PubMed Identifier: 30993686

Publication URI: http://europepmc.org/abstract/MED/30993686

Type: Journal Article/Review

Volume: 106

Parent Publication: Clinical pharmacology and therapeutics

Issue: 3

ISSN: 0009-9236